Tag: Entasis Therapeutics Holdings

Entasis Therapeutics Announces Initial ETX0282 Phase 1 Results

Entasis Therapeutics Holdings (NASDAQ:ETTX) has announced initial preliminary results from its first-in-human Phase 1 clinical trial of its oral beta-lactamase...